# Pharmacogenetics of Warfarin Induction and Inhibition

> **NCT01447511** · NA · COMPLETED · sponsor: **University of Minnesota** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Control - Warfarin only
- **DRUG:** Fluconazole - Warfarin
- **DRUG:** Rifampin - Warfarin

## Key facts

- **NCT ID:** NCT01447511
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447511, "Pharmacogenetics of Warfarin Induction and Inhibition". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT01447511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*